Li et al. reported that, in their study of 124 Chinese patients with PeCa, elevated levels of both CRP ≥ 4.5 mg/l and squamous cell carcinoma antigen (SCCAg) ≥ 1.4 ng/mL were associated with the pathologic tumor and nodal stage, extranodal extension, pelvic lymph node metastases, and cancer-specific survival (CSS). The gene discussed is CRP; the disease is cancer.